These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 698913)

  • 101. Effects of age on responses to treatment and survival of patients with multiple myeloma.
    Cohen HJ; Silberman HR; Forman W; Bartolucci A; Liu C
    J Am Geriatr Soc; 1983 May; 31(5):272-7. PubMed ID: 6841855
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Drug resistance in multiple myeloma associated with high in vitro incorporation of 3H-thymidine.
    Hofmann V; Salmon SE; Durie BG
    Blood; 1981 Sep; 58(3):471-6. PubMed ID: 7259835
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Chemotherapy of advanced prostatic cancer with adriamycin, BCNU, and cyclophosphamide.
    Presant CA; Van Amburg A; Klahr C; Metter GE
    Cancer; 1980 Dec; 46(11):2389-92. PubMed ID: 7438014
    [TBL] [Abstract][Full Text] [Related]  

  • 104. In vitro studies of ways to overcome resistance to VAMP--high dose melphalan in the treatment of multiple myeloma.
    Millar BC; Bell JB; Maitland JA; Zuiable A; Gore ME; Selby PJ; McElwain TJ
    Br J Haematol; 1989 Feb; 71(2):213-22. PubMed ID: 2923807
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Peptichemio induction therapy in myelomatosis.
    Merlini G; Gobbi PG; Riccardi A; Riva G; Sardi C; Perugini S
    Cancer Chemother Pharmacol; 1982; 8(1):9-16. PubMed ID: 7094202
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Progress report on vindesine treatment of melphalan-resistant multiple myeloma.
    van Dobbenburgh OA; Houwen B; Halie MR; Marrink J; Ockhuizen T; Nieweg HO
    Eur J Cancer Clin Oncol; 1983 Jun; 19(6):861-2. PubMed ID: 6683653
    [No Abstract]   [Full Text] [Related]  

  • 107. The chemotherapy of plasma cell myeloma and related disorders.
    Coleman M; Silver RT
    Antibiot Chemother (1971); 1974; 18():112-47. PubMed ID: 4219116
    [No Abstract]   [Full Text] [Related]  

  • 108. Treatment of multiple myeloma.
    Woodruff R
    Cancer Treat Rev; 1981 Dec; 8(4):225-70. PubMed ID: 7039824
    [No Abstract]   [Full Text] [Related]  

  • 109. Treatment of myeloma. Comparison of melphalan, chlorambucil, and azathioprine.
    Arch Intern Med; 1975 Jan; 135(1):157-62. PubMed ID: 1111464
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Factors responsible for bone marrow toxicity after treatment of myeloma patients with different alkylating agents.
    Ringborg U; Lewensohn R
    Acta Med Scand; 1978; 203(4):276-8. PubMed ID: 645439
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Prognostic factors in multiple myeloma.
    Alexanian R; Balcerzak S; Bonnet JD; Gehan EA; Haut A; Hewlett JS; Monto RW
    Cancer; 1975 Oct; 36(4):1192-201. PubMed ID: 1175123
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Influence of age of host on the chemotherapy of murine myeloma LCP-1.
    Teller MN; Bowie M; Mountain IM
    J Gerontol; 1974 Jul; 29(4):360-5. PubMed ID: 4833754
    [No Abstract]   [Full Text] [Related]  

  • 113. Adriamycin plus cyclophosphamide in advanced bronchial carcinoma.
    Tancini G; Marchini S
    Tumori; 1976; 62(4):373-5. PubMed ID: 1020044
    [TBL] [Abstract][Full Text] [Related]  

  • 114. A preliminary study of cyclophosphamide (NSC-26271), adriamycin (NSC-123127), imidazole carboxamide (NSC-45388), and actinomycin D (NSC-3053) with or without MER-BCG in patients with advanced sarcomas.
    Creagan ET; Edmonson JH; Hahn RG; Ahmann DL; Bisel HF; Eagan RT
    Med Pediatr Oncol; 1978; 4(1):85-6. PubMed ID: 625266
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Enhancing the antitumor activity of adriamycin and ionizing radiation.
    Sun W; Kalen AL; Smith BJ; Cullen JJ; Oberley LW
    Cancer Res; 2009 May; 69(10):4294-300. PubMed ID: 19401447
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Optimal control analysis in the chemotherapy of IgG multiple myeloma.
    Swan GW; Vincent TL
    Bull Math Biol; 1977; 39(3):317-37. PubMed ID: 857983
    [No Abstract]   [Full Text] [Related]  

  • 117. Improved survival in multiple myeloma with renal failure.
    Wahlin A; Löfvenberg E; Holm J
    Acta Med Scand; 1987; 221(2):205-9. PubMed ID: 3591456
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Acute leukemia in multiple myeloma.
    Gonzalez F; Trujillo JM; Alexanian R
    Ann Intern Med; 1977 Apr; 86(4):440-3. PubMed ID: 403840
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Tumor growth patterns in multiple myeloma.
    Hokanson JA; Brown BW; Thompson JR; Drewinko B; Alexanian R
    Cancer; 1977 Mar; 39(3):1077-84. PubMed ID: 912647
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Chemotherapy of mouse myeloma: quantitative cell cultures predictive of response in vivo.
    Ogawa M; Bergsagel DE; McCulloch EA
    Blood; 1973 Jan; 41(1):7-15. PubMed ID: 4682084
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.